celebrity writers

Antigenics Inc. (AGEN)

Major Antigenetics Insider Buy after good news on drug success

Feb 13, 2007

Antigenics is a biotechnology company that develops technologies and products to treat cancers, infectious diseases, and autoimmune disorders.

2/13/07 Major Antigenetics (AGEN) Insider Buy

Garo H Armen, CEO and Chairman of the Board bought 50,000 shares today to increase his direct holdings to 106,601 shares.

Chart of AGEN & Discuss AGEN

Indirectly, Mr. Armen holds 11,489,274 shares:

Last week I saw Dr. Dean Edel on TV interview a cancer patient who took Antigenetics' drug for a cancer that should have killed her by now. She seemed to be in remission or at least still alive. The story reported others in the study were getting "an immune response" from I believe they said "all others tested in the study." This story made me wonder if this was "news" that was not announced to shareholders yet since it was a SF Evening news story about the good work being done at USF. I made a mental note to watch this stock for an insider buy on this sort of news.

Ding

Click the SEC Document showing this purchase of 50,000 shares for $96,500 to bring his total to 106,610 shares.

1. Dr. Armen is CEO, Chairman of the Board of Managers and member of Antigenics Holdings ("Holdings") which, as of the date of this report, owns 11,154,274 shares of Antigenics Inc. common stock. Dr. Armen has a pecuniary interest in only a portion ofthe shares held by Holdings and disclaims their beneficial ownership except to the extent of his pecuniary interest therein. Dr. Armen is also General Partner of Armen Partners, LP. Armen Partners, LP owns a total of 335,000 shares of Antigenics common stock. Dr. Armen has a pecuniary interest in only a portion of the shares held by Armen Partners, LP and disclaims their beneficial ownership except to the extent of his pecuniary interest.

Insider purchases are rare. Usually insiders sell after they exercise options. An officer at Intel registered a major stock purchase with the SEC today.

I get these insider reports from a private source. It is from a computer program that monitors the SEC for announcements of insider buying and selling. Now and then, I get a real gem like this announcement that an insider from Antigenetics (AGEN) is buying.

Details:

OFCR/ CEO & Chair o/ Board = Classification of Insider

$96k = Value of I-Buy trade(s)

50k = Number of Shares

$1.93 = Average Price Paid

$1.91 = Recent Stock Price (delayed)

132k = Average Daily Volume (composite timeframe)

$88M = Company Market Capitalization

2007-02-09 = Purchase Date

2007-02-13 = Filing Date

13:21:59 = SEC Arrival TimeStamp

The Insider Roster at Yahoo shows Garo H Armen owned 51,610 shares before today's filing.

Chart of AGEN & Discuss AGEN

Disclaimers:

1. I own AGEN in my personal portfolio and bought 1,000 shares here on this news.

2. I may trade the ups and downs of AGEN in either or both my personal and my newsletter explore portfolios without announcing it here or anywhere else.

3. Answers & my words are general in nature, are not meant as specific investment advice, and do not necessarily represent the opinion of anyone but Kirk. Individuals should consult with their own advisors for specific investment advice.

Kirk Lindstrom:

The copyright of the article Antigenics Inc. (AGEN) in Shares/Stocks is owned by Kirk Lindstrom. Permission to republish Antigenics Inc. (AGEN) in print or online must be granted by the author in writing.

Comments

Apr 11, 2007 9:14 AM

davey52 :

Dipped a foot in the water @ 3.24. Not quite a 50 % retracement of a major market move but oh well. Zacks shows all analyst recommendations are a sell or strong sell, that can only get better. Tick staying green so far. Interesting:)

Apr 13, 2007 10:48 AM

davey52 :

Geez; The bunny with a battery.

Apr 13, 2007 11:18 AM

davey52 :

Two more VERY lucky fills after that. I don't put too much faith in that jinx stuff so just jinx to your hearts content:)

Apr 16, 2007 7:38 AM

davey52 :

2,893,620 buy @4.99--10.31 AM Eastern. Nice

Apr 19, 2007 9:45 AM

davey52 :

A limit order filled @ 3.68. Didn't help my cost basis but I thought I'd give it a try. We'll see:)

Apr 19, 2007 10:43 AM

davey52 :

Hi Kirk; Noticed the tiny gap also. Some gaps never get filled. Keeping my finger near the trigger just in case though:)

Apr 19, 2007 12:39 PM

davey52 :

Well that didn't work very well at all. I think it has something to do with that hideous orange bug cnbc keeps flashing. DOW this much above/this much below Record this record that. They can stop that nonsense any day now.

Apr 20, 2007 7:36 AM

davey52 :

This is a tuff one. A third sold at the open. Just added it back @ 3.35. That tiny gap is looming large Kirk:)

Apr 20, 2007 8:53 AM

davey52 :

Yep Kirk I see what you're saying. This thing is just now catching a solid bid so I'll tag along for a bit longer. And yes, the tests were quite encouraging. Could be some options related things going on also, but I haven't checked on that.

Apr 20, 2007 11:58 AM

davey52 :

A slow steady rise in the bid and ask over the last couple hours. Could it be? LRCX even looks like it wants to go green

Apr 23, 2007 8:16 AM

davey52 :

If there's anything encouraging in this mornings trade, It's Fridays low of 4.26 has held by a penny. There was no shortage of sellers in the first hour. The bid and ask has steadily been improving since. A little green would be just fine by me:)

Apr 24, 2007 10:41 AM

davey52 :

Or you could be doing it with this one today:)

12 Comments